NCT Number: NCT01774994
Arginine and Nitric Oxide (NO) Metabolism in Healthy Human Volunteers
Investigation of arginine and NO metabolism in healthy subjects is important as a reference for alterations in arginine-NO metabolism in patients. Moreover, this study will indicate the changes during aging and gender-related differences. Although data on arginine metabolism exist in literature, data are limited to young healthy male subjects. Since patients with suspected changes in arginine metabolism, e.g. sepsis and cancer patients are often elderly and also women, knowledge of arginine metabolism in these groups is needed.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–70 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Written informed consent
- Age 18-25 years (young); 50-70 years (middle aged/elderly)
Exclusion criteria
- Diabetes mellitus type I
- Livercirrhosis, pancreatitis, malignancies
- Hypertension (diastolic blood pressure >95 mmHg or systolic blood pressure >160 mmHg)
- History of gastrointestinal complaints
- Recent involuntary weight loss (more than 10 % in 6 months or more than 5 % in one month)
- Pregnancy (pregnancy test is done in female subjects)
- Use of medication that can affect arginine metabolism (nitrovasodilators and corticosteroids)
- Subjects with "high activity level"
Treatment and study plan
Primary outcomes
-
whole body NO synthesis
Time frame: 2 hours
postabsorptive nitric oxide synthesis measured by using stable isotope methodology
Secondary outcomes
-
whole body protein metabolism
Time frame: 2 hours
postabsorptive whole body protein metabolism (protein synthesis, breakdown, net protein breakdown) measured by using stable isotope methodology
-
whole body arginine metabolism
Time frame: 2 hours
postabsorptive arginine metabolism measured by using stable isotope methodology
-
blood parameters
Time frame: 2 hours
postabsorptive blood levels (glucose, insulin, urea, amino acids, CRP)
Sponsors and collaborators
Lead sponsor
Maastricht University Medical Center
Other
Registry information
Important dates
- Study start
- 2004
- Primary completion
- 2005
- Study completion
- 2012
- First posted
- Jan 24, 2013
- Registry last updated
- Jan 24, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Tumor-Derived FGF19
NCT06068257
Breast Cancer, Breast Diseases
Orlando, Florida, United States
View Trial DetailsAI Chatbot for HPV Vaccine Literacy Among Caregivers in Japan
NCT06702423
Healthy
London, United Kingdom
View Trial DetailsValidation of the Masimo Irregular Heartbeat Detection Algorithm in Participants Without Cardiovascular Disease
NCT07223164
Healthy
Irvine, California, United States
View Trial DetailsNormative Value for Navicular Drop Test in Older Adults
NCT05595902
Healthy
Kadıköy, Istanbul, Turkey (Türkiye)
View Trial Details